Measurement of mycophenolic acid and its glucuronide using a novel rapid liquid chromatography-electrospray ionization tandem mass spectrometry assay

Clinical Biochemistry

Volumn 42, Issue 1-2, 2009, Pages 83-90

  Kuhn, Joachim ^a   Prante, Christian ^a   Kleesiek, Knut ^a   Götting, Christian ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

EMIT; In source fragmentation; Ion suppression; LC MS MS; Mycophenolic acid; TDM

Indexed keywords

DRUG METABOLITE; EDETIC ACID; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYCOPHENOLIC ACID BETA D GLUCURONIDE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANALYZER; ARTICLE; BLOOD SAMPLING; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG GLUCURONIDATION; DRUG METABOLISM; DRUG MONITORING; ELECTROSPRAY MASS SPECTROMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MASS SPECTROMETER; MEDICAL INSTRUMENTATION; ORGAN TRANSPLANTATION; PLASMA; PRIORITY JOURNAL; SERUM; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, LIQUID; GLUCURONIDES; HUMANS; MYCOPHENOLIC ACID; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 57649101970     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.10.004     Document Type: Article

References (28)

1. Franklin T.J., and Cook J.M. The inhibition of nucleic acid synthesis by mycophenolic acid. Biochem J 113 (1969) 515-524
2. Oellerich M., Shipkova M., Schütz E., et al. Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on mycophenolate mofetil therapy in pediatric renal transplant recipients. Ther. Drug Monit. 22 (2000) 20-26
3. Shaw L.M., Kaplan B., DeNofrio D., Korecka M., and Brayman K.L. Pharmacokinetics and concentration-control investigations of mycophenolic acid in adults after transplantation. Ther. Drug Monit. 22 (2000) 14-19
4. Pawinski T., Durlik M., Szlaska I., Urbanowicz A., Majchrnak J., and Gralak B. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant. J. Clin. Pharm. Ther. 31 (2006) 27-34
5. Bullingham R.E., Nicholls A.J., and Kamm B.R. Clinical pharmacokinetics of mycophenolate mofetil. Clin. Pharmacokinet. 34 (1998) 429-455
6. van Gelder T., Klupp J., Barten M.J., Christians U., and Morris R.E. Comparison of the effect of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid. Ther. Drug Monit. 23 (2001) 119-128
7. Vogl M., Weigel G., Seebacher G., Griesmacher A., Laufer G., and Müller M.M. Evaluation of the EMIT mycophenolic acid assay from Dade Behring. Ther. Drug Monit. 21 (1999) 638-643
8. Shipkova M., Schütz E., Armstrong V.W., Niedmann P.D., Wieland E., and Oellerich M. Overestimation of mycophenolic acid by EMIT correlates with MPA metabolite. Transplant. Proc. 31 (1999) 1135-1137
9. Beal J.L., Jones C.E., Tayler P.J., and Tett S.E. Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with the high-performance liquid chromatography assay. Ther. Drug Monit. 20 (1998) 685-690
10. Premaud A., Rousseau A., Le Meur Y., Lachatre G., and Marquet P. Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring. Ther. Drug Monit. 26 (2004) 609-619
11. Sugioka N., Odani H., Ohta T., Kishimoto T.Y., and Takada K. Determination if a new immunosuppressant, mycophenolate mofetil, and its active metabolite, mycophenolic acid, in rat and human body fluids by high-performance liquid chromatography. J. Chromatogr. B Biomed. Appl. 654 (1994) 249-256
12. Tsina I., Chu F., Hama K., et al. Manual and automated (robotic) high-performance liquid chromatography methods for the determination of mycophenolic acid and its glucuronide conjugate in human plasma. J. Chromatogr. B Biomed. Appl. 675 (1996) 119-129
13. Huang J.J.Z., Kiang H., and Tarnowski T.L. Simultaneous determination of mycophenolic acid and its glucuronide conjugate in human plasma by a single-run ion-paring method. J. Chromatogr. B Biomed. Sci. Appl. 698 (1997) 293-300
14. Na-Bangchang K., Supasyndh O., Supaporn T., Banmairuroi V., and Karbwang J. Simple and sensitive liquid chromatographic method for the determination of mycophenolic acid in plasma. J. Chromatogr. B Biomed. Sci. Appl. 738 (2000) 169-173
15. Sparidans R.W., Hoetelmans R.M., and Beijnen J.H. Liquid chromatographic assay for simultaneous determination of abacavir and mycophenolic acid in human plasma using dual spectrophotometric detection. J. Chromatogr. B Biomed. Sci. Appl. 750 (2001) 155-161
16. Wiwattanawongsa K., Heinzen E.L., Kemp D.C., Dupuis R.E., and Smith P.C. Determination of mycophenolic acid and its phenol glucuronide metabolite in human plasma and urine by high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 763 (2001) 35-45
17. Willis C., Tayler P.J., Salm P., Tett S.E., and Pillans P.I. Quantification of free mycophenolic acid by high-performance liquid chromatography-atmospheric pressure chemical ionisation tandem mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 748 (2000) 151-156
18. Plätzer M., Jahn K., Wohlrab J., and Neubert R. Quantification of mycophenolate mofetil in human skin extracts using high-performance liquid chromatography-electrospray mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 755 (2001) 355-359
19. Streit F., Shipkova M., Armstrong V.W., and Oellerich M. Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid. Clin. Chem. 50 (2004) 152-159
20. Annesley T.M., and Clayton L.T. Quantification of mycophenolic acid and glucuronide metabolite in human serum by HPLC-tandem mass spectrometry. Clin. Chem. 51 (2005) 872-877
21. Schütz E., Shipkova M., Armstrong V.W., et al. Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites. Transplant. Proc. 30 (1998) 1185-1187
22. Shah V.P., Midha K.K., Findlay J.D.H., et al. Bioanalytical method validation-a revisit with a decade of progress. Pharm. Res. 17 (2000) 1551-1557
23. Bossuyt P.M., Reitsma J.B., Bruns D.E., et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Clin. Chem. 49 (2003) 1-6
24. Bossuyt P.M., Reitsma J.B., Bruns D.E., et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Clin. Chem. 49 (2003) 7-18
25. Kuhn J., Götting C., and Kleesiek K. Rapid micro-scale assay for homocysteine by liquid chromatography-tandem mass spectrometry. Clin. Biochem. 39 (2006) 164-166
26. Kuhn J., Prante P., Schön S., Götting G., and Kleesiek K. Measurement of fibrosis marker xylosyltransferase I activity by HPLC electrospray ionization tandem mass spectrometry. Clin. Chem. 52 (2006) 2243-2249
27. Yue B., Rockwood A.L., Sandrock T., La S.L., ulu, Kushnir M.M., and Meikle A.W. Free thyroid hormones in serum by direct equilibrium dialysis and online solid-phase extraction-liquid chromatography/tandem mass spectrometry. Clin. Chem. 54 (2008) 642-651
28. Hideo H., Shiro T., Ryoichi I., et al. Analytic validation of the enzyme multiple immunoassay technique for the determination of mycophenolic acid in plasma from renal transplant recipients compared with high-performance liquid chromatography assay. Ther. Drug Monit. 23 (2001) 669-674